Vanguard Group Inc. Raises Stock Holdings in Avanos Medical, Inc. (NYSE:AVNS)

Vanguard Group Inc. increased its stake in shares of Avanos Medical, Inc. (NYSE:AVNS - Free Report) by 0.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 5,339,778 shares of the company's stock after acquiring an additional 19,476 shares during the period. Vanguard Group Inc. owned about 11.62% of Avanos Medical worth $85,009,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently bought and sold shares of the company. William Blair Investment Management LLC grew its position in Avanos Medical by 2.1% during the fourth quarter. William Blair Investment Management LLC now owns 1,406,210 shares of the company's stock valued at $22,387,000 after buying an additional 28,608 shares during the period. Paradice Investment Management LLC grew its position in shares of Avanos Medical by 2.5% during the 4th quarter. Paradice Investment Management LLC now owns 1,293,198 shares of the company's stock valued at $20,588,000 after acquiring an additional 30,949 shares during the period. Geode Capital Management LLC grew its position in shares of Avanos Medical by 1.5% during the 3rd quarter. Geode Capital Management LLC now owns 1,054,162 shares of the company's stock valued at $25,337,000 after acquiring an additional 16,065 shares during the period. Tributary Capital Management LLC increased its stake in shares of Avanos Medical by 38.1% in the 4th quarter. Tributary Capital Management LLC now owns 893,008 shares of the company's stock valued at $14,217,000 after purchasing an additional 246,379 shares in the last quarter. Finally, Principal Financial Group Inc. raised its holdings in Avanos Medical by 3.5% in the 4th quarter. Principal Financial Group Inc. now owns 237,794 shares of the company's stock worth $3,786,000 after purchasing an additional 7,932 shares during the period. 95.17% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Avanos Medical

In other news, SVP Kerr Holbrook sold 7,000 shares of the company's stock in a transaction that occurred on Thursday, March 6th. The stock was sold at an average price of $15.25, for a total value of $106,750.00. Following the completion of the sale, the senior vice president now directly owns 82,047 shares in the company, valued at $1,251,216.75. This represents a 7.86 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders own 2.64% of the company's stock.

Avanos Medical Price Performance

Shares of AVNS traded down $0.18 during mid-day trading on Tuesday, hitting $12.24. 41,138 shares of the company were exchanged, compared to its average volume of 533,739. Avanos Medical, Inc. has a 1-year low of $12.09 and a 1-year high of $25.36. The company has a 50 day moving average of $14.76 and a 200-day moving average of $17.37. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.46 and a current ratio of 2.22. The stock has a market cap of $562.85 million, a price-to-earnings ratio of 35.99 and a beta of 1.15.

Avanos Medical (NYSE:AVNS - Get Free Report) last issued its quarterly earnings results on Wednesday, February 26th. The company reported $0.43 EPS for the quarter, topping the consensus estimate of $0.40 by $0.03. The firm had revenue of $179.60 million during the quarter, compared to analysts' expectations of $177.23 million. Avanos Medical had a return on equity of 4.70% and a net margin of 2.30%. Analysts expect that Avanos Medical, Inc. will post 1.32 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Separately, StockNews.com upgraded Avanos Medical from a "hold" rating to a "buy" rating in a research report on Wednesday, March 19th.

About Avanos Medical

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.